Physician profile
Helen Luong
NPI 1104842319
$7,204.17
in general payments reported to CMS, 2019-2025
37 companies · $1,030 in 2025
The $1,030 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,598 · 2020: $870 · 2021: $1,377 · 2022: $943 · 2023: $852 · 2024: $534 · 2025: $1,030.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,105 · Education: $311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,104.84 |
| Education | $311.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,726.16 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $1,026.24 | 2021-2025 | |
| Astellas Pharma US INC | $578.41 | 2023-2025 | Veozah |
| Aspira Women'S Health INC | $473.46 | 2019-2023 | Ova1 |
| Avion Pharmaceuticals | $330.93 | 2020-2022 | |
| Pfizer INC. | $271.29 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $268.79 | 2023-2025 | Myfembree, Gemtesa |
| Exeltis, USA INC. | $248.56 | 2022-2025 | Slynd |
| Therapeuticsmd, INC. | $240.83 | 2019-2021 | |
| Evofem Biosciences, INC. | $222.73 | 2020-2022 | |
| Myovant Sciences INC. | $207.30 | 2021-2022 | |
| Millicent US INC | $189.75 | 2024-2025 | Femlyv, Intrarosa, Femring |
| Applied Medical Resources Corporation | $189.45 | 2022 | |
| Davol INC. | $164.47 | 2020-2024 | Arista Ah Flexitip |
| Organon LLC | $149.46 | 2022-2025 | Nexplanon |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $125.41 | 2021-2023 | Twirla |
| Vertical Pharmaceuticals, LLC | $120.56 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $104.93 | 2019 | |
| Amag Pharmaceuticals, INC. | $59.66 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $54.50 | 2022-2025 | |
| Ascend Therapeutics US, LLC | $53.46 | 2019-2021 | |
| Lupin INC. | $51.73 | 2020 | |
| Roche Diagnostics Corporation | $48.27 | 2019 | |
| Coopersurgical, INC. | $43.17 | 2019-2020 | |
| Allergan, INC. | $34.85 | 2020 | |
| Hologic Sales and Service, LLC | $27.25 | 2024 | Aptima |
| Duchesnay USA Incorporated | $24.87 | 2019 | |
| Radius Health, INC. | $22.16 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $20.32 | 2023 | Livalo, Seglentis |
| Meditrina | $20.29 | 2023 | |
| Merck Sharp & Dohme LLC | $17.70 | 2020 | |
| Baxter Healthcare | $16.62 | 2019 | |
| Minerva Surgical, INC | $14.43 | 2019 | |
| Mylan Pharmaceuticals INC. | $14.29 | 2022 | |
| Tactile Systems Technology INC | $14.28 | 2019 | |
| Sun Pharmaceutical Industries INC. | $13.93 | 2021 | |
| Medicem INC. | $13.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Helen Luong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.